4//SEC Filing
Chondros Dimitrios 4
Accession 0001179110-19-002007
CIK 0001159036other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:36 PM ET
Size
8.4 KB
Accession
0001179110-19-002007
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2019-02-14$16.54/sh−2,322$38,406→ 36,067 total - Exercise/Conversion
Common Stock
2019-02-14+6,790→ 38,389 total - Exercise/Conversion
Restricted Stock Units
2019-02-14−6,790→ 20,370 totalExercise: $0.00→ Common Stock (6,790 underlying)
Footnotes (2)
- [F1]The reported disposition of 2,322 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Documents
Issuer
HALOZYME THERAPEUTICS INC
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001739693
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:36 PM ET
- Size
- 8.4 KB